Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific PharmacoScan

Thermo Fisher Scientific has introduced the PharmacoScan, a microarray-based research tool that contains relevant pharmacogenomic markers of the absorption, distribution, metabolism, and excretion (ADME) pathways of commonly prescribed medicines. Using PharmacoScan, researchers can interrogate more than 4,600 markers in nearly 1,200 genes involved in pharmacogenomics pathways with a single assay. The solution is enabled by the Axiom genotyping solution and automated GeneTitan multi-channel array plate processing instrument, and enables lot-to-lot reproducibility and data consistency and high-throughput and affordable sample processing. The product was developed in collaboration with the Clinical Pharmacogenetics Implementation Consortium, PharmaADME, and PharmGKB. Early-access customers include the University of Montreal Hospital Research Centre, the University of Alberta, and leading genomic service laboratories, Thermo Fisher said.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.